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Abstract Extracellular fungal RNases, including ribotoxins
such as K-sarcin, constitute a family of structurally related pro-
teins represented by RNase T1. The tautomeric preferences of
the K-sarcin imidazole side chains have been determined by
nuclear magnetic resonance and electrostatic calculations. His-
tidine residues at the active site, H50 and H137, adopt the NN
tautomer, which is less common in short peptides, as has been
found for RNase T1. Comparison with tautomers predicted
from crystal structures of other ribonucleases suggests that
two active site histidine residues with the NN tautomer are a
conserved feature of microbial ribonucleases and that this is
related to their ribonucleolytic function.
' 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Ribotoxins are highly speci¢c ribonucleases which share a
high degree of sequence identity [1], almost identical struc-
tures [2,3] and modes of action [1,4]. K-Sarcin, produced by
the mold Aspergillus giganteus [5,6] is the best characterized
member of this family of fungal cytotoxins [7,8], and its solu-
tion structure [2], electrostatics [9] and dynamics [10] have
been extensively studied. This secreted ribotoxin inhibits pro-
tein biosynthesis in target cells by cleaving a single phospho-
diester bond in a strictly conserved RNA sequence [11^13]
located in the ‘sarcin/ricin’ loop (SRL) of the large ribosome
subunit [14,15]. It is a small (150 residue) and highly basic
protein (pI 9.4) containing four Arg, eight His and 20 Lys
residues. The histidine residues are widely distributed
throughout the protein structure; some are in regular second-
ary structure elements: K-helix (His 35 and His 36), central L-
sheet (His 50 and His 137); others in loops: loop 2 (His 82
and His 92), loop 3 (His 104); and the C-terminus (His 150)
(Fig. 1). His 50, His 82, His 137 and His 150 have altered pKa
values relative to model compounds and their participation in
electrostatic and structural interactions has been reported [9].
A salt bridge involving His 82 links loops 1 and 2 and has
been proposed to contribute to the conformational stability.
His 150 interacts with the N-terminal region, assisting a di-
sul¢de bridge (Cys 6-Cys 148) maintain the correct orientation
of the N-terminal L-hairpin (important for the SRL interac-
tion) with the central L-sheet. Moreover, histidines 50 and 137
are at the active site (Fig. 2) and their roles in catalysis have
been determined [9,16,17].
The structural and electrostatic properties of histidine resi-
dues depend on the ionization and tautomeric equilibria of
their side chains. The imidazolium cation produces two di¡er-
ent imidazole tautomers upon proton dissociation at high pH,
a free NN or a free NO site. Whereas the tautomeric state is not
determined by X-ray crystal or nuclear magnetic resonance
(NMR) structures, it can be derived from heteronuclear chem-
ical shifts by 2D NMR methods [18,19]. 13C NMR studies on
free histidine have shown a four-to-one preference for the NO^
H tautomer [18]. Moreover, studies on NO or NN methylated
histidine derivatives reveal that the NN microscopic pKa is 0.6
pH units lower than for NO [18,20]. The association of speci¢c
tautomeric states of histidine with metal ligation [21], catalysis
[22] and phosphorylation [23] illustrates the importance of His
tautomerization to biological function.
To better understand the roles played by K-sarcin histidines
in both stabilizing the tertiary structure and in catalysis, we
have analyzed the tautomeric states of the imidazole side
chains of K-sarcin by the well-established 15N^1H 2D NMR
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Fig. 1. Ribbon representation of the solution structure of K-sarcin
illustrating the location of the histidine residues.
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methodology [19,24] and electrostatic calculations [25,26]. The
results reveal that the tautomeric states of the histidines are
important for K-sarcin’s stability and catalytic function.
2. Materials and methods
2.1. NMR
Samples were prepared by dissolving the 15N-labeled wild-type pro-
tein as described previously [9,27]. All spectra were acquired on a
Bruker AMX-600 spectrometer. Two-dimensional 1H^15N HMQC
spectra [28] of K-sarcin were acquired in D2O at pH 8.5 and 35‡C.
The delay during which 15N and 1H signals become antiphase was set
to 22 ms to refocus magnetization arising from 1JNH couplings. A
total of 80 scans were signal-averaged for each of the 128 complex
t1 points. The 15N carrier was set to 210 ppm. Spectra were processed
with Bruker software.
2.2. Theoretical pKa calculations
Calculations were performed on the family of 20 NMR K-sarcin
structures (1DE3) to obtain averaged pKa values for titratable resi-
dues by applying a continuous electrostatic approach that relies on
the ¢nite di¡erence solution of the Poisson^Boltzmann equation
(FDPB) as implemented in the University of Houston Brownian Dy-
namics software package (UHBD) [29,30]. Protocols from Wade and
co-workers [25,26], which explicitly account for multiple site titration,
were used. The dielectric constant was set to 78.5 for solvent and to 15
or 78.5 for sites in the protein depending on their calculated desolva-
tion energy [25]. Calculations were performed at 35‡C with the ionic
strength set to 200 mM. Model compound pKas from Nozaki and
Tanford [31] were used for the reference state.
3. Results
3.1. Experimental determination of the tautomeric state of the
K-sarcin histidine residues
The tautomeric states of K-sarcin histidines were derived
from the pattern of cross-peaks and 15N chemical shifts of
the NO and NN atoms observed in the long-range 1H^15N
correlation spectrum shown in Fig. 3. In such spectra, cross-
peaks of approximately equal intensity are observed for the
NO^HO, NO^HN and NN^HO two-bond correlations [32], while
the cross-peak for the NN^HN three-bond correlation is weak
or absent [32]. Neutral histidines are identi¢ed by well-sepa-
rated nitrogen resonances, 167.5 ppm for protonated nitrogen
and 249.5 ppm for unprotonated nitrogen [19]. In charged
histidine, both nitrogens resonate around 176.5, with the NN
atom generally appearing about 1 ppm lower than the NO
atom [19]. In the K-sarcin spectrum at pH 8.5, signals corre-
sponding to His 35, 50, 92, 137 and 150 are clearly observed
and the tautomer of the neutral state was determined on the
basis of the cross-peak pattern (Table 1). The NN nuclei of His
35, 50, 92, 137, and 150 resonate at 240, 178, 228, 166, and
186 ppm, respectively, and the chemical shifts of the corre-
sponding NO are 171, 203, 184, 248, and 206 ppm, respectively
(Fig. 3). Assuming that these tautomeric equilibria are on the
NMR fast-exchange regime, 15N chemical shifts can be used
semiquantitatively to estimate populations. Using this ap-
proach, the neutral state tautomers of His 137 and His 35
were found to be NN^H and NO^H (v 90%), respectively.
Both these histidines are observed to be completely neutral
at pH 8.5; this is consistent with their low macroscopic
pKas [9]. His 92 is also mainly neutral and the reduced di¡er-
ence between 15N chemical shifts can be explained by a fast
equilibrium (80:20) favoring the NO^H tautomer. His 50 and
His 150 with high pKas are incompletely titrated and partially
charged (56% and 39%, respectively) at pH 8.5. Strikingly, the
intrinsically less common NN tautomer is predominant for
these side chains; neutral His 50 is 84% NN and neutral His
150 is 70% NN.
Ambiguous patterns were found for His 36 and His 104 and
no cross-peaks were detected for His 82, probably due to line
broadening. For His 36, the observation of a broad signal
centered at 206 ppm assignable to either or both ring nitro-
Fig. 2. Schematic drawing of the K-sarcin active site. Side chains of
the catalytic (Glu 96 and His 137) and nearby residues (Tyr 48, His
50, Trp 51 and Arg 121) are shown. His 50 and His 137 are repre-
sented in the neutral state in their preferred tautomer found in the
protein. *Hydrogen bond found in the homologous restrictocin
structure.
Fig. 3. 1H^15N HMBC spectrum of 15N-labeled K-sarcin. Spectra
were taken at pH 8.5 and 308 K.
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gens and quite close to the value estimated for a 1:1 NN :NO
tautomeric equilibrium (208.5 ppm) is evidence that this res-
idue exists as a mixture of tautomers. As only one nitrogen
signal centered at 181 ppm could be assigned to His 104, its
tautomeric state could not be determined on the basis of
NMR data alone.
3.2. Calculation of His pKa values and tautomeric states
Since averaged computed pKas have been reported to be
more accurate than those based on a single structure [30],
we performed calculations using the family of K-sarcin
NMR structures and di¡erent tautomeric states for the neu-
tral forms of histidine residues. The results summarized in
Table 1 correspond to calculations performed with the tauto-
mers determined by 2D-NMR (see above), except for His 82
and His 104 (see below). The closeness of the NN and NO
calculated pKas for His 36 corroborates the 1:1 tautomeric
ratio determined by their 15N resonances. In general, exper-
imental and calculated values are in good agreement.
While no 1H^15N cross-peaks were observed for His 82, the
3D NMR structure shows a hydrogen bond between its NO
proton and the Asp 41 side chain [2]. This is evidence that the
NO tautomer predominates, and this line of reasoning is sup-
ported by the close agreement of the experimental and calcu-
lated pKa values. Alternative calculations considering di¡erent
dielectric environments for the tautomers of His 104 show
that although this site is identi¢ed as having a low dielectric
constant by the UHBD program (values in Table 1), using the
high value for the dielectric constant reproduces the experi-
mental pKa values better. Dynamic processes in this region
revealed by 15N relaxation studies [10] likely a¡ect the dielec-
tric properties around this residue. The fact that the current
version of UHBD does not consider dynamic processes prob-
ably explains its inappropriate choice of the dielectric constant
at this site.
Regarding the active site (Fig. 2), important pKa di¡erences
are observed when calculations with di¡erent tautomers of
His 50 and 137 were performed (Table 2). The pKa of Glu
96 clearly depends on the tautomeric state of His 50 but not
on that of His 137. Interestingly, the Arg 121 pKa is strongly
altered, up to 1.3 pH units, depending on the tautomeric
states of His 137 and His 50. The experimental pKas of active
site residues are better reproduced when the His 137 NN and
His 50 NN combination is chosen.
4. Discussion
Determination of the tautomeric preferences of the K-sarcin
histidines is of special interest to better describe its active site
as well as those of other members of this conserved family of
extracellular ribonucleases. It is well-established that in K-sar-
cin Glu 96 and His 137 serve as the general base and acid,
respectively, in catalysis, whereas the other histidine, His 50, is
likely involved in transition state stabilization during the
transesteri¢cation reaction [16]. The catalytic activity of K-
sarcin depends on the delicate balance of structural and elec-
trostatic interactions, which are a¡ected by the tautomeric
state of the histidines. In particular, di¡erent hydrogen-bond-
ing networks can be established by di¡erent tautomers. The
tautomeric state of K-sarcin His 137 determined in this work
is that expected from the 3D structure in solution since its
NN^H is hydrogen-bonded to the oxygen of Gly 143. The
equivalent proton also is hydrogen-bonded in the K-sarcin
homolog restrictocin [3] and in other microbial RNases whose
Table 1
Experimental and calculated pKa and tautomeric forms of histidine residues of K-sarcin
Residue Experimental Calculated pKa vpKac
tautomera pKab tautomer NO tautomer NN
His 35 NO 6.3U 0.2 6.5U 0.2d ^ 30.2
His 36 NN/NO 6.8U 0.2 6.9U 0.1e 7.1 U 0.1e 30.1/30.3
His 50 NN 7.7U 0.2 ^ 7.2 U 0.1e 0.5
His 82 NO 7.3U 0.1 7.8U 0.1e ^ 30.5
His 92 NO 6.9U 0.1 6.6U 0.1e ^ 0.3
His 104 NN/NO 6.5U 0.2 5.4U 0.2e 5.9 U 0.2e 1.1/0.6
His 137 NN 5.8U 0.1 ^ 5.6 U 0.2d 0.2
His 150 NN 7.6U 0.1 ^ 6.9 U 0.1e 0.7
aTautomer assignment for each histidine was made: on the basis of NMR data, His 35, His 36, His 50, His 92, His 137 and His 150; on the
basis of the 3D structure, His 82; and on the basis of the electrostatic calculations, His 104.
bMacroscopic experimental pKa [9].
cvpKa = pKa(experimental)3pKa(calculated).
d‘Low dielectric’ protein site (dielectric constant, 15).
e‘High dielectric’ protein site (dielectric constant, 78.5).
Table 2
Dependence of the averaged calculated pKa values of the K-sarcin active-site residues as a function of the histidine tautomeric states
Experimentala Calculated pKa
50NO/137NO 50NN/137NO 50NN/137NN
Tyr 48 ^ 9.8U 0.1 9.7U 0.1 9.8U 0.1
His 50 7.7 U 0.2 6.1U 0.1 7.1U 0.1 7.2U 0.1
Glu 96 5.2 U 0.1 3.9U 0.1 4.7U 0.1 4.7U 0.1
Arg 121 ^ 12.7U 0.1 13.3U 0.1 14.0U 0.1
His 137 5.8 U 0.1 4.9U 0.1 5.0U 0.1 5.6U 0.2
aMacroscopic experimental pKa [9].
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substrate-free structure is known [33,34]. This H-bond a¡ects
the electrostatics and structure of the protein [2]. In contrast,
the NMR structure clearly shows that the His 50 side chain is
not involved in hydrogen bonds, so the NO tautomer which is
more stable in solution [32] is expected to be present. The
NMR data and the electrostatic calculations show, however,
that it exists predominantly in the less common NN form. This
is also the tautomer deduced from the crystal structure of the
homologous ribotoxin restrictocin [3] whose corresponding
His 49 NN^H is hydrogen-bonded.
Di¡erences in vG can be calculated from shifts in the tau-
tomer populations. Maintaining a histidine residue in the dis-
favored NN tautomer is not energetically free but destabilizes
the folded conformation of K-sarcin about 2.2 kcal/mol per
His or 4.4 kcal/mol for both active site residues. Why is the
protein willing to bear such a substantial decrease in stability?
The answer, we believe, is revealed by the experimental pKas
and those calculated for the various combinations of His ac-
tive-site tautomers (Table 2). Namely, altering these tautomers
would change the pKas of the active-site groups and decrease
the activity of the protein by reducing or acid-shifting the
activity pro¢le.
Ribotoxins also belong to the larger family of fungal extra-
cellular ribonucleases, usually represented by RNase T1
[35,36]. These RNases have di¡erent biological functions
and enzymatic activities, but all them share a common struc-
tural fold [2,3]. These fungal ribonucleases (St, T1, F1, Ms,
U1, and U2) have two histidines at the active site with the
same conformation as His 50 and His 137 in K-sarcin [1,36].
Recently, the histidine tautomers of RNase T1 have been
reported [37] and show that both active site residues, His 40
and His 92, also adopt the less common NN tautomer in so-
lution though none of these histidine rings is hydrogen-
bonded in the T1 NMR structure [38]. In spite of the known
structural di¡erences between K-sarcin and RNase T1, these
results highlight the similarity of their active sites. No other
study on histidine tautomeric states has been reported for
other members of this family. However, an analysis of the
hydrogen-bonding pattern of active-site histidines can give
some insight into the more probable tautomeric forms. Based
on the known 3D structures, His 40 and His 92 in RNase F1
(1FUS) [39], His 41 and His 101 in RNase U2 (1RTU) [34],
His 39 and His 91 in RNase Ms (1RMS) [40], have the NN
histidine proton involved in hydrogen bonds. In all cases, the
less common NN tautomer is predicted, suggesting a conserved
structure^function link with their ribonucleolytic activity.
With lower levels of sequence similarity, bacterial ribonu-
cleases, like barnase and RNase Sa, are more distant cousins
of the fungal ribonucleases, yet they also conserve an active-
site His homologous to His 137 in K-sarcin. This His has just
been shown to adopt the HN tautomer in RNase Sa [41].
This agrees with the hypothesis that microbial ribotoxins
are naturally engineered proteins derived from ribonucleases
with additional domains extended from the conserved cata-
lytic core [42].
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